Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
When to Initiate a Notification For a definition of tuberculosis (TB) patient classifications, see the “Tuberculosis Classification System” topic in the Diagnosis of Tuberculosis Disease section. Table 1: TRANSFER NOTIFICATIONS AND FOLLOW-UPS 2 Referral Type When to Initiate Notes Verified and suspected cases of tuberculosis (TB) disease Contacts After identifying a: Latent TB Infection (LTBI) converters When notified that a Class 3 or 5 patient is moving or has moved from the area for 30 days or more High-priority contact to a smearpositive Class 3 or Class 5 pulmonary case Contact to a smear-negative Class 3 pulmonary case Contact to a highly suspect Class 5 pulmonary case When notified that a documented convertor who has initiated treatment is moving or has moved from the area for 30 days or more LTBI reactors When notified that a Class 2 or 4 patient who has initiated treatment is moving or has moved from the area for 30 days or more Source case investigation for TB disease Source case investigation for LTBI After identifying a close associate to a Class 3 index case with clinical presentation consistent with recently acquired disease After identifying a close associate to a child with LTBI May also initiate to coordinate directly observed therapy (DOT) while patient is visiting another area. Send individual referrals for each contact. Use primarily for associates to children under 5 years of age with TB disease. A younger age cut-off may be advisable because the focus would be on more recent transmission. 3 Use primarily for associates to children under 2 years of age with LTBI. 4 A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Transfer Notifications 15.4 Revised November 2012
Follow-Up Type When to Initiate Notes Final disposition When final status and/or outcome is known Source: NTCA. Interjurisdictional Tuberculosis (TB) Notification—National Tuberculosis Controllers Association Recommendations. Smyrna, GA: March 2002:1–5. A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Transfer Notifications 15.5 Revised November 2012
- Page 301 and 302: Note: An IGRA may be used in place
- Page 303 and 304: When to Expand a Contact Investigat
- Page 305 and 306: Figure 7: EVALUATION, TREATMENT, AN
- Page 307 and 308: CDC’s “Framework of Program Eva
- Page 309 and 310: Definitions of abbreviations: AIDS
- Page 311 and 312: elease assay; LTBI = latent tubercu
- Page 313 and 314: officials to distinguish between di
- Page 315 and 316: References 1 ATS, CDC, IDSA. Contro
- Page 317 and 318: 44 CDC, NTCA. Guidelines for the in
- Page 319 and 320: Introduction Purpose Use this secti
- Page 321 and 322: Available Laboratory Tests Table 2:
- Page 323 and 324: Table 3: PCR Testing Algorithm and
- Page 325 and 326: Table 4: SPECIMEN COLLECTION METHOD
- Page 327 and 328: 5. If possible, send the specimen o
- Page 329 and 330: Specimen Shipment There are three m
- Page 331 and 332: Resources and References Resources
- Page 333 and 334: Patient Education CONTENTS Introduc
- Page 335 and 336: treatment, common side-effects of m
- Page 337 and 338: Education Topics During the initial
- Page 339 and 340: 10. Explain the signs and symptoms
- Page 341 and 342: Patient Education Materials Get th
- Page 343 and 344: References 1 CDC. Module 4: treatme
- Page 345 and 346: Introduction Purpose Use this secti
- Page 347 and 348: National Guidelines The following g
- Page 349 and 350: Transfer Notifications CONTENTS Int
- Page 351: For roles and responsibilities, ref
- Page 355 and 356: Action Transfers Within Alaska Tran
- Page 357 and 358: Provide the patient with a. A copy
- Page 359 and 360: References 1 CDC. International not
- Page 361 and 362: Infection Control CONTENTS Introduc
- Page 363 and 364: of TB infection control principles
- Page 365 and 366: Administrative Activities 13 Key ac
- Page 367 and 368: Personal Respiratory Protection Alt
- Page 369 and 370: For regulations in your area, refer
- Page 371 and 372: Employee Health All employees, phys
- Page 373 and 374: Figure 1: TWO STEP TESTING AND FOLL
- Page 375 and 376: Isolation To reduce disease transmi
- Page 377 and 378: Table 4: CRITERIA FOR PATIENTS TO B
- Page 379 and 380: When to Initiate Airborne Infection
- Page 381 and 382: Confirmed Tuberculosis Disease A pa
- Page 383 and 384: Multidrug-Resistant Tuberculosis Di
- Page 385 and 386: Environmental Controls in the Patie
- Page 387 and 388: Return to Work, School, or Other So
- Page 389 and 390: Tuberculosis Infection Control in P
- Page 391 and 392: Transportation Vehicles To prevent
- Page 393 and 394: 7 CDC. Guidelines for preventing th
- Page 395 and 396: Forms: Alaska State Public Health L
- Page 397 and 398: ALASKA STATE PUBLIC HEALTH LABORATO
- Page 399 and 400: Anchorage Alaska State Public Healt
- Page 401 and 402: INDEX CASE INFORMATION Name: DOB: /
When to Initiate a Notification<br />
For a definition <strong>of</strong> tuberculosis (TB) patient classifications, see the<br />
“<strong>Tuberculosis</strong> Classification System” topic in the Diagnosis <strong>of</strong> <strong>Tuberculosis</strong><br />
Disease section.<br />
Table 1: TRANSFER NOTIFICATIONS AND FOLLOW-UPS 2<br />
Referral Type When to Initiate Notes<br />
Verified and suspected<br />
cases <strong>of</strong> tuberculosis<br />
(TB) disease<br />
Contacts After identifying a:<br />
Latent TB Infection<br />
(LTBI) converters<br />
When notified that a Class 3 or 5<br />
patient is moving or has moved from<br />
the area for 30 days or more<br />
High-priority contact to a smearpositive<br />
Class 3 or Class 5<br />
pulmonary case<br />
Contact to a smear-negative Class<br />
3 pulmonary case<br />
Contact to a highly suspect Class<br />
5 pulmonary case<br />
When notified that a documented<br />
convertor who has initiated treatment<br />
is moving or has moved from the<br />
area for 30 days or more<br />
LTBI reactors When notified that a Class 2 or 4<br />
patient who has initiated treatment is<br />
moving or has moved from the area<br />
for 30 days or more<br />
Source case<br />
investigation for TB<br />
disease<br />
Source case<br />
investigation for LTBI<br />
After identifying a close associate to<br />
a Class 3 index case with clinical<br />
presentation consistent with recently<br />
acquired disease<br />
After identifying a close associate to<br />
a child with LTBI<br />
May also initiate to coordinate directly<br />
observed therapy (DOT) while patient is<br />
visiting another area.<br />
Send individual referrals for each<br />
contact.<br />
Use primarily for associates to children<br />
under 5 years <strong>of</strong> age with TB disease. A<br />
younger age cut-<strong>of</strong>f may be advisable<br />
because the focus would be on more<br />
recent transmission. 3<br />
Use primarily for associates to children<br />
under 2 years <strong>of</strong> age with LTBI. 4<br />
A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Transfer Notifications 15.4<br />
Revised November 2012